Recce Pharmaceuticals Ltd
RECEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $81,880 | $221,817 | $183,730 | $121,356 |
| - Cash | $10,449 | $1,944 | $4,415 | $4,009 |
| + Debt | $10,768 | $4,741 | $811 | $199 |
| Enterprise Value | $82,200 | $224,613 | $180,126 | $117,546 |
| Revenue | $563 | $6,946 | $0 | $2,381 |
| % Growth | -91.9% | – | -100% | – |
| Gross Profit | -$1,493 | -$1,444 | -$173 | $2,188 |
| % Margin | -265.4% | -20.8% | – | 91.9% |
| EBITDA | -$13,296 | -$6,988 | -$12,079 | -$9,275 |
| % Margin | -2,363.7% | -100.6% | – | -389.5% |
| Net Income | -$13,693 | -$7,735 | -$10,200 | -$7,462 |
| % Margin | -2,434.2% | -111.4% | – | -313.3% |
| EPS Diluted | -0.056 | -0.034 | -0.05 | -0.042 |
| % Growth | -65.4% | 32.4% | -20.2% | – |
| Operating Cash Flow | -$13,518 | -$6,924 | -$6,491 | -$6,517 |
| Capital Expenditures | -$8 | -$18 | -$36 | -$106 |
| Free Cash Flow | -$13,527 | -$6,942 | -$6,527 | -$6,624 |